-transparent.png){kind=logo}
A double-blind randomized study to evaluate the effect of proflavine in the treatment of genital herpesvirus infection was conducted. One hundred fifty-seven women were studied, of whom 75 were treated with proflavine (treated women) and 82 were treated with placebo (control group). There were 62 women with primary disease and 95 with recurrent infection. Under the conditions by which this study was conducted, there was no apparent difference in the time of healing of lesions, development of recurrences, or virus isolation following treatment in the proflavine-treated and control groups.
Related Publications
R H Kaufman, and
E Adam, and
R R Mirkovic, and
J L Melnick, and
R L Young
April 1977,
Photochemistry and photobiology,
R H Kaufman, and
E Adam, and
R R Mirkovic, and
J L Melnick, and
R L Young
January 1982,
Nursing times,
R H Kaufman, and
E Adam, and
R R Mirkovic, and
J L Melnick, and
R L Young
December 2005,
Clinical obstetrics and gynecology,
R H Kaufman, and
E Adam, and
R R Mirkovic, and
J L Melnick, and
R L Young
June 1976,
The Journal of infectious diseases,
R H Kaufman, and
E Adam, and
R R Mirkovic, and
J L Melnick, and
R L Young
November 1976,
Photochemistry and photobiology,
R H Kaufman, and
E Adam, and
R R Mirkovic, and
J L Melnick, and
R L Young
January 1982,
The Journal of infection,
R H Kaufman, and
E Adam, and
R R Mirkovic, and
J L Melnick, and
R L Young
April 1977,
Photochemistry and photobiology,
R H Kaufman, and
E Adam, and
R R Mirkovic, and
J L Melnick, and
R L Young
March 1977,
Annals of the New York Academy of Sciences,
R H Kaufman, and
E Adam, and
R R Mirkovic, and
J L Melnick, and
R L Young
September 1976,
Nippon Ganka Gakkai zasshi,
R H Kaufman, and
E Adam, and
R R Mirkovic, and
J L Melnick, and
R L Young
January 1985,
Epidemiologic reviews,
